Results 11 to 20 of about 1,201,269 (362)

Adjuvant Chemotherapy

Thoracic Surgery Clinics, 2020
UMEROUS TYPES OF ADJUVANT CHEMOTHER- N apy are being used on cancer. Of these, 4 are discussed in this paper: (1) systemic administration of the drug at the time of operation, (2) instillation of anticancer agents into the lumen of the colon, (3 ...
Warren, Cole, R. Mrázek, D. Slaughter, F. Strehl, D. M., Steven, Economou, Gerald, Mcdonald   +9 more
semanticscholar   +5 more sources

Chemotherapy adjuvant and chemotherapy-induced neutropenia

Taiwanese Journal of Obstetrics & Gynecology, 2022
Yiu-Tai Li, Szu-Ting Yang, Peng-Hui Wang
doaj   +3 more sources

Adjuvant Chemotherapy [PDF]

CA: A Cancer Journal for Clinicians, 1986
At present, adjuvant chemotherapy exerts no significant impact on long-term survival and only occasionally provides brief palliation in head and neck cancer. The major contribution of chemotherapy has been in the preoperative period, when therapy for advanced squamous cell carcinoma may render some patients candidates for curative operations or ...
Charles A. Coltman, C. Kent Osborne
openaire   +5 more sources

Adjuvant chemotherapy for medulloblastoma [PDF]

Cancer, 1985
The use of adjuvant chemotherapy for cerebellar medulloblastoma is controversial. Twenty-one children and adolescents were treated with adjuvant low-dose cyclophosphamide and vincristine following surgery and radiotherapy. With a mean observation period of 6 years, the disease-free survival is 81%.
Sue McIntosh, Charles Duncan, Peggy A. Sartain, Michael Chen, Allen D. Schwartz, Joan L. Venes, Ethelyn H. Klatskin, Robert Fishburn   +7 more
openaire   +3 more sources

A small footprint couch‐top support device for image‐guided radiotherapy of heavy patients

Journal of Applied Clinical Medical Physics, Volume 23, Issue 12, December 2022., 2022
Abstract Purpose Patients with body weights close to or above 400 lbs present unique challenges in radiation therapy since the weight limit of most treatment couches decreases as the couch‐top extends toward the treatment gantry. The purpose of this work was to develop a small footprint couch‐top support platform to safely perform image‐guided ...
Huixiao Chen, Kevin Morley, Ronnie Rodriguez, Emily Draeger, Muhammad Shafiq ul Hassan, Zhe (Jay) Chen   +5 more
wiley   +1 more source

Clinical Outcomes in Early Breast Cancer With a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy: A Secondary Analysis of the TAILORx Randomized Clinical Trial.

JAMA Oncology, 2020
Importance A high 21-gene recurrence score (RS) by breast cancer assay is prognostic for distant recurrence of early breast cancer after local therapy and endocrine therapy alone, and for chemotherapy benefit.
J. Sparano, R. Gray, D. Makower, K. Albain, T. Saphner, S. Badve, L. Wagner, V. Kaklamani, M. Keane, H. Gómez, P. Reddy, T. Goggins, I. Mayer, D. Toppmeyer, A. Brufsky, M. Goetz, J. Berenberg, Catalin Mahalcioiu, C. Desbiens, D. Hayes, E. Dees, C. Geyer, J. Olson, W. Wood, T. Lively, S. Paik, M. Ellis, J. Abrams, G. Sledge   +28 more
semanticscholar   +1 more source

Improved overall survival is associated with adjuvant chemotherapy after definitive concurrent chemoradiotherapy for N3 nasopharyngeal cancer

Scientific Reports, 2022
Concurrent chemoradiotherapy is the established treatment for locally advanced nasopharyngeal carcinoma (NPC). However, there is no evidence supporting routine adjuvant chemotherapy. We aimed to demonstrate the effect of adjuvant chemotherapy on survival
Mu-Hung Tsai, Shang-Yin Wu, Hsi-Huei Lu, Tsung Yu, Sen-Tien Tsai, Yuan-Hua Wu   +5 more
doaj   +1 more source

Adjuvant chemotherapy and survival outcomes in rectal cancer patients with good response (ypT0-2N0) after neoadjuvant chemoradiotherapy and surgery: A retrospective nationwide analysis

Frontiers in Oncology, 2022
BackgroundFor rectal cancer, it remains unclear how to incorporate tumor response to neoadjuvant chemoradiotherapy (nCRT) when deciding whether to give adjuvant chemotherapy.
Yu-Hsuan Kuo, Yu-Hsuan Kuo, Yun-Tzu Lin, Chung-Han Ho, Chung-Han Ho, Chia-Lin Chou, Chia-Lin Chou, Li-Chin Cheng, Chia-Jen Tsai, Wei-Ju Hong, Yi-Chen Chen, Ching-Chieh Yang, Ching-Chieh Yang   +12 more
doaj   +1 more source

Evaluation of Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX Treatment.

JAMA Oncology, 2020
Importance The benefit of adjuvant chemotherapy after resection of pancreatic cancer following neoadjuvant combination treatment with folinic acid, fluorouracil, irinotecan, and oxaliplatin (FOLFIRINOX) is unclear.
S. Roessel, E. Veldhuisen, S. Klompmaker, Q. Janssen, M. Hilal, A. Alseidi, A. Alseidi, A. Balduzzi, G. Balzano, C. Bassi, F. Berrevoet, M. Bonds, O. Busch, G. Butturini, M. Chiaro, K. Conlon, M. Falconi, I. Frigerio, G. Fusai, J. Gagnière, O. Griffin, T. Hackert, A. Halimi, U. Klaiber, K. Labori, G. Malleo, M. Marino, M. Mortensen, A. Nikov, M. Lesurtel, T. Keck, J. Kleeff, R. Pandé, P. Pfeiffer, D. Pietrasz, K. Roberts, Antonio Sa Cunha, R. Salvia, O. Strobel, T. Tarvainen, P. Bossuyt, H. Laarhoven, J. Wilmink, B. Koerkamp, M. Besselink   +44 more
semanticscholar   +1 more source

Whether Patients With Stage Ⅱ/Ⅲ Colorectal Cancer Benefit From Adjuvant Chemotherapy: A Modeling Analysis of Literature Aggregate Data

Frontiers in Pharmacology, 2022
Objective: This study used model analysis to clarify the benefits and risks of postoperative adjuvant chemotherapy compared with surgery alone in patients with stage II/III colorectal cancer.Methods: Clinical trials involving patients with stage II/III ...
Sijie Zha, Ting Li, Qingshan Zheng, Lujin Li   +3 more
doaj   +1 more source